EXAGEN INC. Operating Cash Flow
EXAGEN INC. (XGN) reported Operating Cash Flow of -$6.43 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-04
- EXAGEN INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was $3.99M.
- EXAGEN INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$10.42M.
- EXAGEN INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$3.01M, a 930.03% decline year-over-year.
- EXAGEN INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was $2.94M.
- EXAGEN INC. net cash provided by (used in) operating activities for fiscal 2025 was -$13.63M.
- EXAGEN INC. net cash provided by (used in) operating activities for fiscal 2024 was -$13.28M.
- EXAGEN INC. net cash provided by (used in) operating activities for fiscal 2023 was -$14.46M.
- EXAGEN INC. net cash provided by (used in) operating activities for fiscal 2022 was -$32.14M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$6.43M 10-Q · filed 2026-08-04 | -$9.44M derived: sum of 3 quarters · filed 2026-08-04 | -$6.50M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | -$10.42M 10-Q · filed 2026-05-11 | -$13.43M derived: sum of 2 quarters · filed 2026-05-11 | -$10.49M derived: sum of 3 quarters · filed 2026-05-11 | -$13.37M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | -$3.01M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | -$69.00K derived: sum of 2 quarters · filed 2026-03-10 | -$2.95M derived: sum of 3 quarters · filed 2026-08-04 | -$13.63M 10-K · filed 2026-03-10 |
| 2025-09-30 | $2.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $59.00K derived: sum of 2 quarters · filed 2026-08-04 | -$10.61M 10-Q · filed 2025-11-04 | -$10.25M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | -$2.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$13.56M 10-Q · filed 2026-08-04 | -$13.19M derived: sum of 3 quarters · filed 2026-08-04 | -$15.37M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | -$10.67M 10-Q · filed 2026-05-11 | -$10.31M derived: sum of 2 quarters · filed 2026-05-11 | -$12.48M derived: sum of 3 quarters · filed 2026-05-11 | -$14.91M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $363.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | -$1.81M derived: sum of 2 quarters · filed 2026-03-10 | -$4.24M derived: sum of 3 quarters · filed 2026-03-10 | -$13.28M 10-K · filed 2026-03-10 |
| 2024-09-30 | -$2.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$4.60M derived: sum of 2 quarters · filed 2025-11-04 | -$13.64M 10-Q · filed 2025-11-04 | -$5.29M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | -$2.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | -$11.47M 10-Q · filed 2025-07-29 | -$3.12M derived: sum of 3 quarters · filed 2025-07-29 | -$6.03M derived: sum of 4 quarters · filed 2025-07-29 |
| 2024-03-31 | -$9.04M 10-Q · filed 2025-05-05 | -$691.00K derived: sum of 2 quarters · filed 2025-05-05 | -$3.60M derived: sum of 3 quarters · filed 2025-05-05 | -$13.75M derived: sum of 4 quarters · filed 2025-05-05 |
| 2023-12-31 | $8.35M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $5.44M derived: sum of 2 quarters · filed 2025-03-11 | -$4.71M derived: sum of 3 quarters · filed 2025-03-11 | -$14.46M 10-K · filed 2025-03-11 |
| 2023-09-30 | -$2.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$13.06M derived: sum of 2 quarters · filed 2024-11-12 | -$22.81M 10-Q · filed 2024-11-12 | -$28.55M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | -$10.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | -$19.90M 10-Q · filed 2024-08-05 | -$25.64M derived: sum of 3 quarters · filed 2024-08-05 | -$32.32M derived: sum of 4 quarters · filed 2024-08-05 |
| 2023-03-31 | -$9.75M 10-Q · filed 2024-05-13 | -$15.48M derived: sum of 2 quarters · filed 2024-05-13 | -$22.16M derived: sum of 3 quarters · filed 2024-05-13 | -$33.32M derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | -$5.73M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-18 | -$12.42M derived: sum of 2 quarters · filed 2024-03-18 | -$23.57M derived: sum of 3 quarters · filed 2024-03-18 | -$32.14M 10-K · filed 2024-03-18 |
| 2022-09-30 | -$6.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$17.84M derived: sum of 2 quarters · filed 2023-11-13 | -$26.41M 10-Q · filed 2023-11-13 | -$32.46M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | -$11.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | -$19.73M 10-Q · filed 2023-08-07 | -$25.77M derived: sum of 3 quarters · filed 2023-08-07 | -$31.23M derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | -$8.57M 10-Q · filed 2023-05-15 | -$14.62M derived: sum of 2 quarters · filed 2023-05-15 | -$20.08M derived: sum of 3 quarters · filed 2023-05-15 | -$24.53M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | -$6.05M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | -$11.51M derived: sum of 2 quarters · filed 2023-03-20 | -$15.96M derived: sum of 3 quarters · filed 2023-03-20 | -$20.27M 10-K · filed 2023-03-20 |
| 2021-09-30 | -$5.46M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2022-11-21 | -$9.91M derived: sum of 2 quarters · filed 2022-11-21 | -$14.22M 10-Q · filed 2022-11-21 | -$18.12M derived: sum of 4 quarters · filed 2022-11-21 |
| 2021-06-30 | -$4.45M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2022-11-21 | -$8.76M 10-Q/A · filed 2022-11-21 | -$12.66M derived: sum of 3 quarters · filed 2022-11-21 | -$14.79M derived: sum of 4 quarters · filed 2022-11-21 |
| 2021-03-31 | -$4.31M 10-Q · filed 2022-05-11 | -$8.21M derived: sum of 2 quarters · filed 2022-05-11 | -$10.34M derived: sum of 3 quarters · filed 2022-05-11 | -$15.10M derived: sum of 4 quarters · filed 2022-05-11 |
| 2020-12-31 | -$3.90M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | -$6.03M derived: sum of 2 quarters · filed 2022-03-22 | -$10.78M derived: sum of 3 quarters · filed 2022-03-22 | -$14.08M 10-K · filed 2022-03-22 |
| 2020-09-30 | -$2.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$6.88M derived: sum of 2 quarters · filed 2021-11-10 | -$10.19M 10-Q · filed 2021-11-10 | -$14.11M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | -$4.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$8.06M 10-Q · filed 2021-08-09 | -$11.98M derived: sum of 3 quarters · filed 2021-08-09 | -$13.65M derived: sum of 4 quarters · filed 2021-08-09 |
| 2020-03-31 | -$3.30M 10-Q · filed 2021-05-11 | -$7.23M derived: sum of 2 quarters · filed 2021-05-11 | -$8.89M derived: sum of 3 quarters · filed 2021-05-11 | -$11.06M derived: sum of 4 quarters · filed 2021-05-11 |
| 2019-12-31 | -$3.93M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | -$5.59M derived: sum of 2 quarters · filed 2021-03-16 | -$7.76M derived: sum of 3 quarters · filed 2021-03-16 | -$9.71M 10-K · filed 2021-03-16 |
| 2019-09-30 | -$1.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | -$3.83M derived: sum of 2 quarters · filed 2020-11-10 | -$5.78M 10-Q · filed 2020-11-10 | -$7.65M derived: sum of 4 quarters · filed 2020-11-10 |
| 2019-06-30 | -$2.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-28 | -$4.12M 10-Q · filed 2020-07-28 | -$5.99M derived: sum of 3 quarters · filed 2020-07-28 | |
| 2019-03-31 | -$1.95M 10-Q · filed 2020-05-11 | -$3.82M derived: sum of 2 quarters · filed 2020-05-11 | ||
| 2018-12-31 | -$1.87M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-25 | -$9.30M 10-K · filed 2020-03-25 | ||
| 2018-09-30 | -$7.43M 10-Q · filed 2019-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |